Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05842564

Autophagy in Paediatric Crohn's Disease

Autophagic Activity Characterization in Pediatric Crohn's Disease

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Crohn's disease is a multifactorial complex disease resulting in a between microbiota and immune system. Indeed, GWAS (Genome-Wide Association Studies) association study pinpointed polymorphisms as genes susceptibility on more than 200 loci. Among them genes coding for proteins involved in autophagy machinery (i.e: ATG16L1, IRGM et NDP52). Autophagy is a ubiquitous intracellular mechanism mandatory for protein and microorganism recycling. So far, the role of autophagy in gut inflammation and intestinal homeostasis in Crohn's disease patients is partially understand. Then, investigators plan to evaluate, on native cells, the autophagic flux in pediatric patients suffering of a Crohn's disease compare to controls.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplesBlood sample of maximum 20ml (5 tubes of EDTA of 4ml or 5 tubes of EDTA of 2ml and a tube for the conservation of genomic DNA)
OTHERBiopsies5 biopsies (one for each segment of the intestine explored: ileum, right colon, transverse colon left colon and sigmoid) will be taken during the ileocolonoscopy

Timeline

Start date
2025-01-01
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2023-05-06
Last updated
2024-12-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05842564. Inclusion in this directory is not an endorsement.